Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 23, (9391-9396) DOI: 10.1073/pnas.0812884106);Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 23, 2009, Pages 9391-9396

  Barnett, Edward M ^a   Zhang, Xu ^a   Maxwell, Dustin ^b   Chang, Qing ^a   Piwnica Worms, David ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caspase; Molecular imaging; Near infrared fluorescence

Indexed keywords

CASPASE; CASPASE 3; CELL PENETRATING PEPTIDE; N METHYL DEXTRO ASPARTIC ACID; TAT CELL PENETRATING PEPTIDE Q; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVATION; ENZYME ACTIVITY; GLAUCOMA; HISTOPATHOLOGY; IN VIVO STUDY; ISOMER; MOLECULAR IMAGING; NEAR INFRARED SPECTROSCOPY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; STEREOSPECIFICITY;

RATTUS;

EID: 67249095097     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0906521106     Document Type: Erratum

References (46)

1. Marks N, Berg MJ (1999) Recent advances on neuronal caspases in development and neurodegeneration. Neurochem Int 35:195-220. (Pubitemid 29320083)
2. Reed J (2001) Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 7:314-319. (Pubitemid 32606571)
3. Riedl S, Salvesen G (2007) The apoptosome: Signalling platform of cell death. Nat Rev Mol Cell Biol 8:405-413. (Pubitemid 46643237)
4. Opferman J, Korsmeyer S (2003) Apoptosis in the development and maintenance of the immune system. Nat Immunol 4:410-415. (Pubitemid 36592430)
5. Krysko D, Vanden Berghe T, D'Herde K, Vandenabeele P (2008) Apoptosis and necrosis: Detection, discrimination and phagocytosis. Methods 44:205-221. (Pubitemid 351296447)
6. Schoenberger J, Bauer J, Moosbauer J, Eilles C, Grimm D (2008) Innovative strategies in in vivo apoptosis imaging. Curr Med Chem 15:187-194. (Pubitemid 351234622)
7. Quigley HA (1996) Number of people with glaucoma worldwide. Br J Ophthalmol 80:389-393.
8. Nickells R (1999) Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death. Surv Ophthalmol 43:S151-161.
9. Quigley HA (1999) Neuronal death in glaucoma. Prog Retin Eye Res 18:39-57. (Pubitemid 28457038)
10. Cordeiro M, et al. (2004) Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci USA 101:13352-13356. (Pubitemid 39209669)
11. Fonge H, et al. (2008) Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys- annexin A5 as an apoptosis imaging agent. Bioorg Med Chem Lett 18:3794-3798. (Pubitemid 351794510)
12. Keen HG, et al. (2005) Imaging apoptosis in vivo using 124I-annexin V and PET. Nucl Med Biol 32:395-402. (Pubitemid 40692689)
13. Quinti L, Weissleder R, Tung CH (2006) A fluorescent nanosensor for apoptotic cells. Nano Lett 6:488-490.
14. Guo L, et al. (2005) Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 46:175-182. (Pubitemid 40041195)
15. Maass A, et al. (2007) Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes. Curr Eye Res 32:851-861. (Pubitemid 350034783)
16. Schmitz-Valckenberg S, et al. (2008) Real-time in vivo imaging of retinal cell apoptosis after laser exposure. Invest Ophthalmol Vis Sci 49:2773-2780.
17. Ashe PC, Berry MD (2003) Apoptotic signaling cascades. Prog Neuropsychopharmacol Biol Psychiatry 27:199-214. (Pubitemid 36351488)
18. Bullok K, Piwnica-Worms D (2005) Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem 48:5404-5407. (Pubitemid 41209236)
19. Bullok KE, et al. (2007) Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Biochemistry 46:4055-4065. (Pubitemid 46536069)
20. Barnett EM, Elangovan B, Bullok KE, Piwnica-Worms D (2006) Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Invest Ophthalmol Vis Sci 47:2589-2595. (Pubitemid 351639846)
21. Pang IH, Clark AF (2007). Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma 16:483-505. (Pubitemid 47263052)
22. Inomata Y, et al. (2006) Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina. J Neurochem 98:372-385. (Pubitemid 44133143)
23. Lam TT, Abler AS, Kwong JM, Tso MO (1999) N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 40:2391-2397. (Pubitemid 29418396)
24. Manabe S, Gu Z, Lipton SA (2005) Activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 46:4747-4753. (Pubitemid 44264580)
25. Tezel G, WaxM(1999) Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest Ophthalmol Vis Sci 40:2660-2667. (Pubitemid 29455497)
26. Bullok K, et al. (2006) Permeation peptide conjugates for in vivo molecular imaging applications. Mol Imaging 5:1-15.
27. Costantini D, Hu M, Reilly R (2008) Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications. Cancer Biother Radiopharm 23:3-24. (Pubitemid 351304218)
28. Fischer R, Fotin-Mleczek M, Hufnagel H, Brock R (2005) Break on through to the other side - biophysics and cell biology shed light on cell-penetrating peptides. Chembiochem 6:2126-2142. (Pubitemid 46259982)
29. Goun EA, Pillow TH, Jones LR, Rothbard JB, Wender PA (2006) Molecular transporters: Synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging. Chembiochem 7:1497-1515. (Pubitemid 44555995)
30. Jiang T, et al. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 101:17867-17872. (Pubitemid 40051978)
31. Messerli S, et al. (2004) A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 6:95-105. (Pubitemid 38544597)
32. Dietz G, Bahr M (2004) Delivery of bioactive molecules into the cell: The Trojan horse approach. Mol Cell Neurosci 27:85-131. (Pubitemid 39370094)
33. Langedijk JP, Olijhoek T, Schut D, Autar R, Meloen RH (2004) New transport peptides broaden the horizon of applications for peptidic pharmaceuticals. Mol Divers 8:101-111. (Pubitemid 39012545)
34. Lindgren M, Hallbrink M, Prochiantz A, Langel U (2000) Cell-penetrating peptides. Trends Pharmacol Sci 21:99-103. (Pubitemid 30114324)
35. Wender PA, Galliher WC, Goun EA, Jones LR, Pillow TH (2008) The design of guanidinium-rich transporters and their internalization mechanisms. Adv Drug Delivery Rev 60:452-472.
36. Dietz GP, Kilic E, Bahr M (2002) Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol Cell Neurosci 21:29-37. (Pubitemid 35178497)
37. Koh HJ, et al. (2004) Intraocular properties of urokinase-derived antiangiogenic A6 peptide in rabbits. J Ocul Pharmacol Ther 20:439-449. (Pubitemid 39441784)
38. Lau J, Dang M, Hockmann K, Ball AK (2005) Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Exp Eye Res 82:319-326.
39. 99mTc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjug Chem 13:1226-1237.
40. Denicourt C, Dowdy SF (2003) Protein transduction technology offers novel therapeutic approach for brain ischemia. Trends Pharmacol Sci 24:216-218. (Pubitemid 36588866)
41. Harbour J, Worley L, Duanduan M, Cohen M (2002) Transducible peptide therapy for uveal melanoma and retinoblastoma. Arch Ophthalmol 120:1341-1346. (Pubitemid 36105439)
42. Polyakov V, et al. (2000) Novel Tat-peptide chelates for direct transduction of technetium- 99m and rhenium into human cells for imaging and radiotherapy. Bioconjug Chem 11:762-771.
43. Zhang X, Cheng M, Chintala SK (2004) Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest Ophthalmol Vis Sci 45:2374-2383. (Pubitemid 38902612)
44. Kermer P, Klocker N, Labes M, Bahr M (1998) Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci 18:4656-4662. (Pubitemid 28280174)
45. Perche O, Doly M, Ranchon-Cole I (2007) Caspase-dependent apoptosis in light-induced retinal degeneration. Invest Ophthalmol Vis Sci 48:2753-2759. (Pubitemid 351261230)
46. Neufeld AH, Sawada A, Becker B (1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 96:9944-9948. (Pubitemid 29398837)